Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Rauf, Haznedar"'
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 3, Pp 231-235 (2016)
Objective: Non-responsiveness to hepatitis B virus (HBV) vaccines is not rare in hemato-oncological patients due to disease-associated or treatment-induced immune suppression. Although different strategies have been employed to improve the response r
Externí odkaz:
https://doaj.org/article/239906aebeee4a32b124c7bd9ea138ca
Publikováno v:
Cancer Investigation. 35:195-201
We hypothesized the levels of free light chains obtained before and after autologous stem cell transplantation can be useful in predicting transplantation outcome. We analyzed 70 multiple myeloma patients. Abnormal free light chain ratios before stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba749a759b91ed9cf153c6fcde41b62e
https://doi.org/10.1080/07357907.2016.1270958
https://doi.org/10.1080/07357907.2016.1270958
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 58(6)
Introduction To investigate the role of urine immunofixation electrophoresis in detecting relapse in patients with myeloma who have undergone autologous and allogeneic hematopoietic stem cell transplantation (HSCT). Methods The study included a total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b9d3028645b3eafff49fcdd3642f07
https://pubmed.ncbi.nlm.nih.gov/31734164
https://pubmed.ncbi.nlm.nih.gov/31734164
Aim: The aim of the study was to evaluate angiogenesis-related parameters including vascular endothelial growth factor (VEGF), p300 expression, and microvessel density (MVD) in plasma cell myeloma (PCM). Material and Method: p300, VEGF, and Factor re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39c159f7beac4eff6312812df0fff9d
https://avesis.gazi.edu.tr/publication/details/57dc2b16-58e4-4fc1-8321-8b68bf11f390/oai
https://avesis.gazi.edu.tr/publication/details/57dc2b16-58e4-4fc1-8321-8b68bf11f390/oai
Autor:
Mehmet, Dağlı, Taner, Demirer, Meltem, Aylı, Rauf, Haznedar, Nazan, Günel, Gülsan, Sucak, Turgay, Fen, Meltem, Moran, Tülay, Üstün, Celalettin, Aybirdi, Mustafa, Çavuşoğlu, Süleyman, Dinçer, Akın, Uysal
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c53a20328a1709823974b76d1945739b
https://pubmed.ncbi.nlm.nih.gov/27265191
https://pubmed.ncbi.nlm.nih.gov/27265191
Autor:
Gülsan Türköz Sucak, Ümit BaĞriaçik, Şahika Zeynep Akı, Münci Yağci, Rauf Haznedar, Bilgehan YüzbaşioĞlu, Nalân Akyürek
Publikováno v:
Leukemia & Lymphoma. 52:1281-1289
Angiogenesis is important for the proliferation and metastasis of most malignant neoplasms including multiple myeloma (MM). The aim of this study was to evaluate the role of bone marrow angiogenesis and angiogenic cytokines in patients with MM prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e952ed67e5dce9b68ca4adeb59b5c843
https://doi.org/10.3109/10428194.2011.569695
https://doi.org/10.3109/10428194.2011.569695
Publikováno v:
Klimik Dergisi/Klimik Journal. 24:24-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22bb636acb4d416dc8c305086a1e2347
https://doi.org/10.5152/kd.2011.05
https://doi.org/10.5152/kd.2011.05
Autor:
Cyrille Hulin, Fabian Termorshuizen, Ingemar Turesson, Meral Beksac, Tommaso Caravita, Pieter Sonneveld, Lotfi Benboubker, Peter Fayers, Peter Gimsing, Pierre W. Wijermans, Philippe Moreau, Rauf Haznedar, Jean Yves Mary, Martijn R. Schaafsma, Pellegrino Musto, Sara Bringhen, Antonio Palumbo, Anders Waage, Thierry Facon
Publikováno v:
Blood, 118(5), 1239-1247. American Society of Hematology
The role of thalidomide for previously untreated elderly patients with multiple myeloma remains unclear. Six randomized controlled trials, launched in or after 2000, compared melphalan and prednisone alone (MP) and with thalidomide (MPT). The effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd3c408efa7fd443817b844fac992a6
https://pure.eur.nl/en/publications/a56bcc99-fe22-4c56-aff4-cd9222307b3a
https://pure.eur.nl/en/publications/a56bcc99-fe22-4c56-aff4-cd9222307b3a
Autor:
Sema Karakus, Gülsan Türköz Sucak, Gülsüm Özet, Meral Beksac, Isik Kaygusuz, Levent Undar, Hakan Goker, Hakan Ozdogu, Rauf Haznedar, Ismet Aydogdu, Zafer Gulbas, Rıdvan Ali, Emin Kaya, Nahide Konuk, Tulin Firatli-Tuglular
Publikováno v:
European Journal of Haematology. 86:16-22
The combination of melphalan-prednisone-thalidomide (MPT) has been investigated in several clinical studies that differed significantly with regard to patient characteristics and treatment schedules. This prospective trial differs from previous melph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e37bfa44d1cc8ad77b56cfef0920f5c
https://doi.org/10.1111/j.1600-0609.2010.01524.x
https://doi.org/10.1111/j.1600-0609.2010.01524.x
Publikováno v:
Journal of International Medical Research. 37:1365-1374
This study aimed to investigate the activity of the antioxidant enzyme superoxide dismutase (SOD) in the three main cell types in chronic myeloproliferative disorders (CMPD) patients, i.e. polymorphonuclear leucocytes (PMNLs), erythrocytes and thromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac482b95693a00674bfa92406819f7a7
https://doi.org/10.1177/147323000903700511
https://doi.org/10.1177/147323000903700511